Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hersil is a prominent Peruvian pharmaceutical company headquartered in Lima, dedicated to the research, development, and production of pharmaceutical and nutritional products. Established in 1965, the company has built a robust portfolio encompassing therapeutic areas such as respiratory health, gastroenterology, and cardiology, alongside a well-known line of natural supplements like PVM. In addition to its own brands, Hersil provides high-quality contract manufacturing and representation services for several multinational laboratories. The company operates a modern manufacturing facility that adheres to international Good Manufacturing Practices (GMP). In late 2022, Hersil was acquired by the Brazilian pharmaceutical giant Eurofarma, strengthening Eurofarma's footprint in the Andean region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hersil Laboratorios Industriales.